Management of nephrotoxicity of chemotherapy and targeted agents: 2020.
Varsha Chiruvella, Pavan Annamaraju, Achuta Kumar Guddati
Abstract
Nephrotoxic effects of certain chemotherapeutic agents such as cisplatin and ifosfamide has been well documented and these effects are carefully managed by oncologists during their usage. The introduction of targeted agents has added a new challenge to cancer management as their nephrotoxic effects and associated management is in the process of being adopted by oncologists. This work is a compilation of side effects on the renal system due to various chemotherapeutic, immunotherapeutic and targeted agents followed by their recommended management.
Topics & Concepts
NephrotoxicityIfosfamideMedicineCisplatinChemotherapyPharmacologyTargeted therapyCancer researchCancerOncologyKidneyInternal medicineChemotherapy-induced organ toxicity mitigationAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia Treatments